Product Information
MYCOPHENOLIC ACID DR 180 MG TB is a generic product labeled by TWi Pharmaceuticals, Inc., priced at $0.0996 per EA under NDC 24979016044. Its NADAC has been published 227 times since Jun 1, 2022.
FDA first approved this application on Nov 3, 2021.
Strength
180 mg/1
Manufacturer
TWi Pharmaceuticals, Inc.NDC
24979016044
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MYCOPHENOLATE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA214289FDA Approved
11/3/2021
On Market Since
11/8/2021
Pharmacological Classes
Price Statistics
The NADAC for MYCOPHENOLIC ACID DR 180 MG TB has been published 227 times since Jun 1, 2022, and over the history we have for it it has declined 70.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0996 per EA |
|---|---|
| All-time high | $0.5348 (Jul 13, 2022) |
| All-time low | $0.0985 (Aug 19, 2026) |
| 52-week high | $0.1449 |
| 52-week low | $0.0985 |
| Median price | $0.1617 |
| Average price | $0.1833 |
| Largest weekly change | +56.9% (Jun 22, 2022) |
| Weeks tracked | 227 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
TWi Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
mycophenolic acid market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimetabolite Immunosuppressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MYCOPHENOLIC ACID DR 180 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for MYCOPHENOLIC ACID DR 180 MG TB, manufactured by TWi Pharmaceuticals, Inc., is $0.0996 per EA (NDC 24979016044), effective Sep 30, 2026.
How has the price of MYCOPHENOLIC ACID DR 180 MG TB changed over time?
Over the history we have for it, the NADAC for MYCOPHENOLIC ACID DR 180 MG TB has declined 70.8%. It has been tracked across 227 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for MYCOPHENOLIC ACID DR 180 MG TB?
Since Jun 1, 2022, the NADAC for MYCOPHENOLIC ACID DR 180 MG TB has ranged from a low of $0.0985 (Aug 19, 2026) to a high of $0.5348 (Jul 13, 2022), with a median of $0.1617 per EA.
Are there cheaper alternatives to MYCOPHENOLIC ACID DR 180 MG TB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MYCOPHENOLIC ACID DR 180 MG TB in a comparable dosage form, but none are currently priced below it.
Who manufactures MYCOPHENOLIC ACID DR 180 MG TB?
MYCOPHENOLIC ACID DR 180 MG TB (NDC 24979016044) is labeled by TWi Pharmaceuticals, Inc., and CMS classifies it as a generic product.